Upgrade to SI Premium - Free Trial

TD Cowen on DexCom (DXCM): 'Outperformance from Top to Bottom-line'

July 31, 2026 10:29 AM
TD Cowen analyst Joshua Jennings reiterated a Buy rating and $95.00 price target on DexCom (NASDAQ: DXCM).The analyst commented: "Outperformance ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments